상세정보
- 상세정보
Vaccines, Medicines and COVID-19 How Can WHO Be Given a Stronger Voice? [electronic resource]
Velásquez, Germán
- 책이미지
-
- 도서 상세정보
- 서평쓰기
| 자료유형 | 단행본 |
|---|---|
| 개인저자 | Velásquez, Germán.,author. |
| 단체저자명 | SpringerLink (Online service). |
| 서명/저자사항 | Vaccines, Medicines and COVID-19 [electronic resource] : How Can WHO Be Given a Stronger Voice? / by Germán Velásquez. |
| 판사항 | 1st ed. 2022. |
| 형태사항 | XVI, 117 p:online resource. |
| 총서사항 | SpringerBriefs in Public Health=2192-3701 |
| 총서부출표목 | SpringerBriefs in Public Health, |
| 기본자료 저록 | Springer Nature eBook |
| 기타형태 저록 | Printed edition:9783030891244Printed edition:9783030891268 |
| ISBN | 9783030891251 |
| 기타표준부호 | 10.1007/978-3-030-89125-1 |
| 내용주기 | Chapter 1: COVID-19 Vaccines: Between Ethics, Health and Economics -- Chapter 2: Medicines and Intellectual Property: 10 Years of the WHO Global Strategy -- Chapter 3: Re-thinking Global and Local Manufacturing of Medical Products After COVID-19 -- Chapter 4: Rethinking R&D for Pharmaceutical Products After the Novel Coronavirus COVID-19 Shock -- Chapter 5: Intellectual Property and Access to Medicines and Vaccines -- Chapter 6: The World Health Organization Reforms in the Time of COVID-19 -- Epilogue. |
| 이용제한사항 | Open Access |
| 요약 | This open access book is a collection of research papers on COVID-19 by Germán Velásquez from 2020 and early 2021 that help to answer the question: How can an agency like the World Health Organization (WHO) be given a stronger voice to exercise authority and leadership? The considerable health, economic and social challenges that the world faced at the beginning of 2020 with COVID-19 continued and worsened in many parts of the world in the second-half of 2020 and into 2021. Many of these countries and nations wanted to explore COVID-19 on their own, sometimes without listening to the main international health bodies such as WHO, an agency of the United Nations system with long-standing experience and vast knowledge at the global level and of which all countries in the world are members. In this single volume, the chapters present the progress of thinking and debate — particularly in relation to drugs and vaccines — that would enable a response to the COVID-19 pandemic or to subsequent crises that may arise. Among the topics covered: COVID-19 Vaccines: Between Ethics, Health and Economics Medicines and Intellectual Property: 10 Years of the WHO Global Strategy Re-thinking Global and Local Manufacturing of Medical Products After COVID-19 Rethinking R&D for Pharmaceutical Products After the Novel Coronavirus COVID-19 Shock Intellectual Property and Access to Medicines and Vaccines The World Health Organization Reforms in the Time of COVID-19 Vaccines, Medicines and COVID-19: How Can WHO Be Given a Stronger Voice? is essential reading for negotiators from the 194 member countries of the World Health Organization (WHO); World Trade Organization (WTO) and World Intellectual Property Organization (WIPO) staff participating in these negotiations; academics and students of public health, medicine, health sciences, law, sociology and political science; and intergovernmental organizations and non-governmental organizations that follow the issue of access to treatments and vaccines for COVID-19. |
| 일반주제명 | Medicine, Preventive. Health promotion. Medical policy. Vaccines -- Biotechnology. Biomaterials. Public health. Health Promotion and Disease Prevention. Health Policy. Biomaterials-Vaccines. Public Health. |
| 바로가기 | URL |